Tag : Alemtuzumab

Latest News

Comparative analysis of melphalan versus busulphan T-cell deplete conditioning using alemtuzumab in unrelated donor stem cell transplantation for acute myeloid leukaemia

Newsemia
Sellar, RS; Mehra, V; Fox, TA; Grigg, A; Kulasekararaj, A; Sarma, A; de Lavallade, H; … Potter, VT; + view all Sellar, RS; Mehra, V;...
Latest News

Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis

Newsemia
John, N; Carroll, A; Brownlee, WJ; Chataway, J; (2019) Switching from natalizumab to alemtuzumab in patients with relapsing multiple sclerosis. [Letter]. Journal of Neurology, Neurosurgery...
Neurology

PRAC Restricts Use of Alemtuzumab for MS Pending Ongoing Review

Newsemia
The EMA committee recommends updating the product information to note the potential for acute immune-mediated conditions, stroke, cervicocephalic arterial dissection, and severe neutropenia. News Alerts...
Neurology

Single-arm study to assess comprehensive infusion guidance for the prevention and management of the infusion associated reactions (IARs) in relapsing-remitting multiple sclerosis (RRMS) patients treated with alemtuzumab (EMERALD).

Newsemia
Related Articles Single-arm study to assess comprehensive infusion guidance for the prevention and management of the infusion associated reactions (IARs) in relapsing-remitting multiple sclerosis (RRMS)...
Neurology

Years of Thyroid Monitoring Needed After MS Drug Alemtuzumab

Newsemia
New study shows fluctuating patterns of thyroid dysfunction and later onset than previously seen associated with the MS drug alemtuzumab, suggesting the need for ongoing...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy